Brief: Virpax Pharmaceuticals Announces Extension Of Crada With The U.S. Army Institute Of Surgical Research
12/10/2023 13:42
Oct 12 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX PHARMACEUTICALS ANNOUNCES EXTENSION OF CRADA WITH
THE
U.S. ARMY INSTITUTE OF SURGICAL RESEARCH
* VIRPAX PHARMACEUTICALS- CRADA WITH U.S. ARMY INSTITUTE OF
SURGICAL RESEARCH TO EVALUATE VIRPAX'S PROBUDUR HAS BEEN
EXTENDED TO SEPTEMBER OF 2024
Source text for Eikon: ID:nBw1Wl6zba
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study